Allogene Therapeutics ALLO
NASDAQ ALLO
$1.54 -0.06 (-3.75%)
At close: Oct 1, 2026 · 4:00 PM EDT

Allogene Therapeutics (ALLO) Shares Outstanding (Diluted) (2019 - 2026)

Updated

Allogene Therapeutics' Shares Outstanding (Diluted) was 328.93 million in Q2 2026, up 50.2% from 218.93 million a year earlier and up 36.9% from the prior quarter.

Analysis

Allogene Therapeutics (ALLO) Shares Outstanding (Diluted) (2019 - 2026) Analysis & Trends

For FY2025, Shares Outstanding (Diluted) at Allogene Therapeutics came in at 220.62 million, up 13.2% from FY2024.

  • Shares Outstanding (Diluted) has now increased for six consecutive years, with a five-year compound annual growth rate of 12.9% (FY2020 to FY2025).
  • In earlier years, Shares Outstanding (Diluted) was 194.81 million in FY2024 (+24.1%), 156.93 million in FY2023 (+9.6%), 143.15 million in FY2022 (+5.4%) and 135.82 million in FY2021 (+12.8%).
  • The Q2 2026 figure marks the highest quarterly Shares Outstanding (Diluted) in data going back to Q4 2019.
  • Compared with a year earlier, Shares Outstanding (Diluted) has increased for 23 straight quarters, with growth averaging 21.6% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Shares Outstanding (Diluted) ranged from 2.3% (Q1 2023) to 50.2% (Q2 2026).
  • Per Business Quant data, ALLO's Shares Outstanding (Diluted) in the three quarters before Q2 2026 was 240.29 million (Q1 2026), 220.62 million (Q4 2025) and 222.04 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.44 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.96 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.56 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 544.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 255.20 Mn
10 Allogene Therapeutics 552.55 Mn 552.55 Mn - 328.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 328.93 Mn
Mar 31, 2026 240.29 Mn
Dec 31, 2025 220.62 Mn
Sep 30, 2025 222.04 Mn
Jun 30, 2025 218.93 Mn
Mar 31, 2025 215.36 Mn
Dec 31, 2024 194.81 Mn
Sep 30, 2024 209.19 Mn
Jun 30, 2024 190.03 Mn
Mar 31, 2024 169.13 Mn
Dec 31, 2023 156.93 Mn
Sep 30, 2023 167.65 Mn
Jun 30, 2023 146.80 Mn
Mar 31, 2023 144.56 Mn
Dec 31, 2022 143.15 Mn
Sep 30, 2022 143.66 Mn
Jun 30, 2022 143.39 Mn
Mar 31, 2022 141.36 Mn
Dec 31, 2021 135.82 Mn
Sep 30, 2021 137.03 Mn
API Access

Allogene Therapeutics Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=ALLO&period=max&api_key=YOUR_API_KEY